相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HER2 discordance between primary breast cancer and its paired metastasis: tumor biology or test artefact? Insights through meta-analysis
Nehmat Houssami et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Trastuzumab Emtansine: A Unique Antibody-Drug Conjugate in Development for Human Epidermal Growth Factor Receptor 2-Positive Cancer
Patricia M. LoRusso et al.
CLINICAL CANCER RESEARCH (2011)
Cetuximab in the treatment of patients with colorectal cancer
Christopher R. Garrett et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2011)
EGFR inhibitors with concurrent thoracic radiation therapy for locally advanced non-small cell lung cancer
Yaping Xu et al.
LUNG CANCER (2011)
Feedback regulation of EGFR signalling: decision making by early and delayed loops
Roi Avraham et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Trastuzumab-Based Neoadjuvant Therapy in Patients With HER2-Positive Breast Cancer
Helena R. Chang
CANCER (2010)
Treatment strategy for HER2-positive breast cancer
Hirofumi Mukai
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2010)
New Antibody Conjugates in Cancer Therapy
Serengulam V. Govindan et al.
THESCIENTIFICWORLDJOURNAL (2010)
ERBB1 and ERBB2 Have Distinct Functions in Tumor Cell Invasion and Intravasation
Dmitriy Kedrin et al.
CLINICAL CANCER RESEARCH (2009)
EGFR, HER2, and HER3 expression in laryngeal primary tumors and corresponding metastases
Qichun Wei et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Trastuzumab: triumphs and tribulations
R. Nahta et al.
ONCOGENE (2007)
TheEGF receptor family: spearheading a merger of signaling and therapeutics
Erez M. Bublil et al.
CURRENT OPINION IN CELL BIOLOGY (2007)
Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific affibody molecule
Vladimir Tolmachev et al.
CANCER RESEARCH (2007)
Potentiation of high-LET radiation by gemcitabine: Targeting HER2 with trastuzumab to treat disseminated peritoneal disease
Diane E. Milenic et al.
CLINICAL CANCER RESEARCH (2007)
[Lu-177]pertuzumab: Experimental therapy of HER-2-expressing xenografts
Mikael Persson et al.
CANCER RESEARCH (2007)
The epidermal growth factor receptor pathway: A model for targeted therapy
Maurizio Scaltriti et al.
CLINICAL CANCER RESEARCH (2006)
EGF-ERBB signalling: towards the systems level
Ami Citri et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Prognostic significance of HER3 and HER4 protein expression in colorectal adenocarcinomas
P Kountourakis et al.
BMC CANCER (2006)
Adjuvant trastuzumab: A milestone in the treatment of HER-2-positive early breast cancer
Jose Baselga et al.
ONCOLOGIST (2006)
Expression of the epidermal growth factor receptor family in normal and malignant urothelium
R Rotterud et al.
BJU INTERNATIONAL (2005)
ERBB receptors and cancer: The complexity of targeted inhibitors
NE Hynes et al.
NATURE REVIEWS CANCER (2005)
Analysis of HER2 expression in primary urinary bladder carcinoma and corresponding metastases
T Gårdmark et al.
BJU INTERNATIONAL (2005)
Monoclonal antibody therapy of cancer
GP Adams et al.
NATURE BIOTECHNOLOGY (2005)
Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence
E Hernes et al.
BRITISH JOURNAL OF CANCER (2004)
Outcome and human epidermal growth factor receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labelling
SM Tovey et al.
BREAST CANCER RESEARCH (2004)
c-erbB-2 oncoprotein expression related to chemoradioresistance in esophageal squamous cell carcinoma
M Akamatsu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
HER-2 -: A possible target for therapy of metastatic urinary bladder carcinoma
K Wester et al.
ACTA ONCOLOGICA (2002)
Investigation of the prognostic value of coexpressed erbB family members for the survival of colorectal cancer patients after curative surgery
JC Lee et al.
EUROPEAN JOURNAL OF CANCER (2002)
Incidence of chromosomal imbalances in advanced colorectal carcinomas and their metastases
T Knösel et al.
VIRCHOWS ARCHIV (2002)
分享论文
